Krsnaa Diagnostics Ltd

NSE: KRSNAA · BSE: 543328 · Healthcare · 33 announcements

Share price: ₹550.00
Market cap: ₹1,784 Cr
Revenue (annual): ₹772.8 Cr
Net profit (annual): ₹101.4 Cr
P/E (TTM): 18.3×Sector 53.1×
Promoter holding: 27.11%+0.00% QoQ
FII holding: 4.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17 Apr 2026 16:46 IST BSE

Krsnaa Diagnostics Board Meeting Outcome

Krsnaa Diagnostics announced its Board Meeting outcome involving the appointment of Mr. Raju Venkatraman and Ms. Lilian Jessie Paul as Independent Directors. Additionally, Mr. Chandra Prakash Singh was named Interim CFO. Several directors completed their tenures, and the Board reconstituted various committees including Audit and Risk Management to strengthen corporate governance effective April 25, 2026.

Read the filing ↗

16 Apr 2026 20:41 IST BSE

Annual General Meeting

Krsnaa Diagnostics Annual General Meeting

Krsnaa Diagnostics Ltd announced the approval of Mr. Rajendra Khivraj Mutha's re-appointment as Executive Chairman for five years via postal ballot. The ordinary resolution was passed with a 99.99% majority on April 16, 2026. The remote e-voting results and scrutinizer's report have been submitted to the exchanges.

Read the filing ↗

4 Apr 2026 14:37 IST BSE

Other Announcement

Krsnaa Diagnostics Other Announcement

Krsnaa Diagnostics Ltd submitted its quarterly confirmation certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The certificate, issued by KFin Technologies, confirms compliance regarding the dematerialization of securities. This is a routine regulatory filing with no material impact on business operations.

Read the filing ↗